GlobeNewsWire
21 Oct 2026, 21:32 UTC · 2h ago
UNCY FINAL DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - UNCY
Impact · against what's priced in
The notification of a lead plaintiff deadline for a securities class action introduces potential legal liability and future cash outflows for Unicycive Therapeutics. This represents a new negative risk factor that may impact the company's balance sheet over the next 12-24 months.
- UNCY−0.20
No priced-in read yet





